About Cellective BioTherapy

About company

Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. The biotechnology company focuses on the research and development of B cell-based cellular therapies for immunomodulation, immunodeficiency, and autoimmunity. It researches about treatment for cancers, diabetes, asthma, and congenital and acquired immunodeficiency, and vaccine development. Cellective BioTherapy was founded by Dr. Thomas F. Tedder in April 2015. It is based in Raleigh, North Carolina.